Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Risperidone and Haloperidol for Prevention of Relapse in Subjects With Schizophrenia and Schizoaffective Disorders

NCT00253110 is registered in ClinicalTrials.gov with Janssen, LP as lead sponsor.

NCT NCT00253110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00253110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Risperidone and Haloperidol for Prevention of Relapse in Subjects With Schizophrenia and Schizoaffective Disorders
Lead sponsor
Janssen, LP
Phase
Phase 4
Overall status
Completed
Start date
May 31, 1996
Completion date
September 30, 1998
Enrollment
396 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia